MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Diffusion-Weighted MRI Becoming Major Tool to Diagnose Patients with Transient Ischemic Attacks

By MedImaging International staff writers
Posted on 20 Aug 2014
Print article
Image: The ischemic penumbra is visible in some patients up to 24 hour after stroke by MRI scanning. Perfusion-weighted imaging can be used to show areas of ischemia and can be compared with the ischemic core, visible by diffusion-weighted imaging (Photo courtesy of sharinginginhealth dot ca, an open access training in healthcare resource).
Image: The ischemic penumbra is visible in some patients up to 24 hour after stroke by MRI scanning. Perfusion-weighted imaging can be used to show areas of ischemia and can be compared with the ischemic core, visible by diffusion-weighted imaging (Photo courtesy of sharinginginhealth dot ca, an open access training in healthcare resource).
With the development of brain imaging, including cranial computed tomography (CCT), and particularly diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI), the diagnosis of transient ischemic attacks (TIAs) has changed from time-based definition to a tissue-based one. DWI-MRI became an essential tool in the TIA workup.

Several studies have shown that TIA patients had cerebral infarctions that can be identified by CCT, even though the CCT was performed days to weeks after the TIA. It has been found that 3%–48% of patients with clinical TIA symptoms had acute cerebral infarctions that can be visualized by CCT. Moreover, the DWI-MRI measurements have shown that up to 67% of patients with TIA demonstrate relevant cerebral infarction.

The development of brain imaging and its use in the routine diagnostic workup of patients with TIA has therefore changed the investigators outlook of TIAs. Particularly, the definition of TIA has shifted from a clinically time-based term to tissue-related one in the clinical daily routine.

The risk of stroke after TIA in patients with evidence of acute infarction ranged between 3 to 18-fold higher than TIA patients without acute infarction detected by MRI. Therefore, TIA should be handled as an emergency event and patients suffering from TIA should be immediately treated to evaluate the etiology and to receive the secondary prophylaxis to prevent a stroke. The impact of the immediate evaluation of TIA patients on stroke prevention after TIA has been shown in earlier studies. Conversely, there are no uniform international guidelines and recommendations for TIA diagnosis and treatment, particularly in diagnostic and therapeutic procedures.

The DWI-MRI provides not only the evidence to differentiate between TIA and acute ischemic stroke; furthermore, it predicts TIA patients who are at higher risk of disabling stroke, which can be prevented by an immediate evaluation and treatment of TIA, according to Dr. Mohamed Al-Khaled from the University of Lübeck (Germany).

The brain imaging in patients with transient neurologic symptoms can help to answer the question that whether patients with TIA who have an acute infarction should be classified as acute ischemic stroke. Furthermore, it has been established that TIA patients who showed acute infarction by DWI-MRI or CCT are at a higher risk to suffer from an incapacitating stroke.

These findings were published in the June/July 2014 issue of the journal Neural Regeneration Research (2014; vol. 9, no. 3).

Related Links:

University of Lübeck


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Needle Guide
Ultra-Pro II
New
Pre-Op Planning Solution
Sectra 3D Trauma
New
Ultrasound Table
Ergonomic Advantage (EA) Line

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more